Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

NCT00620074 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped See Detailed Description

Conditions

Aspergillosis

Interventions

DRUG: voriconazole
DRUG: anidulafungin

Sponsor

Pfizer